MDxHealth (MDXH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
MDxHealth (MDXH) last issued guidance on August 13, 2026 for fiscal year 2026. The company guided revenue in the range of $110M - $115M for the period.
Compared to prior guidance, MDxHealth maintained its revenue forecast from a prior range of $110M - $115M.
MDxHealth has issued 27 guidance updates between November 29, 2022 and August 13, 2026. During this period, the company raised its outlook 8 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | FY '21 |
|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||||
| Estimate | $-0.18 | $-0.15 | $-0.13 | $-0.12 | — |
| Actual | $-0.18 | $-0.17 | $-0.17 | $-0.16 | $-0.24 |
| Surprise | 0.00% | -13.3% | -30.8% | -33.3% | — |
| Revenue | |||||
| Estimate | $23.2M | $27.2M | $26.0M | $25.6M | — |
| Actual | $27.2M | $27.4M | $29.5M | $27.4M | $22.2M |
| Surprise | +17.5% | +0.58% | +13.6% | +7.06% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.09 | $-0.08 | $-0.11 | $-0.09 |
| Revenue | ||||
| Consensus | $25.3M | $27.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.18 | $-0.18 | 0.00 % |
| Q1 | May 13, 2026 | $-0.17 | $-0.15 | -13.3 % |
| Q4 | Feb 26, 2026 | $-0.17 | $-0.13 | -30.8 % |
| Q3 | Nov 12, 2025 | $-0.16 | $-0.12 | -33.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $27.20M | $23.16M | 17.5 % |
| Q1 | May 13, 2026 | $27.39M | $27.23M | 0.58 % |
| Q4 | Feb 26, 2026 | $29.55M | $26.02M | 13.6 % |
| Q3 | Nov 12, 2025 | $27.43M | $25.62M | 7.06 % |